0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Different Chronic Stress Paradigms Converge on Endogenous TDP43 Cleavage and Aggregation

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The TAR-DNA binding protein (TDP43) is a nuclear protein whose cytoplasmic inclusions are hallmarks of Amyotrophic Lateral Sclerosis (ALS). Acute stress in cells causes TDP43 mobilization to the cytoplasm and its aggregation through different routes. Although acute stress elicits a strong phenotype, is far from recapitulating the years-long aggregation process. We applied different chronic stress protocols and described TDP43 aggregation in a human neuroblastoma cell line by combining solubility assays, thioflavin-based microscopy and flow cytometry. This approach allowed us to detect, for the first time to our knowledge in vitro, the formation of 25 kDa C-terminal fragment of TDP43, a pathogenic hallmark of ALS. Our results indicate that chronic stress, compared to the more common acute stress paradigm, better recapitulates the cell biology of TDP43 proteinopathies. Moreover, we optimized a protocol for the detection of bona fide prions in living cells, suggesting that TDP43 may form amyloids as a stress response.

          Supplementary Information

          The online version contains supplementary material available at 10.1007/s12035-023-03455-z.

          Related collections

          Most cited references91

          • Record: found
          • Abstract: found
          • Article: not found

          Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

          Ubiquitin-positive, tau- and alpha-synuclein-negative inclusions are hallmarks of frontotemporal lobar degeneration with ubiquitin-positive inclusions and amyotrophic lateral sclerosis. Although the identity of the ubiquitinated protein specific to either disorder was unknown, we showed that TDP-43 is the major disease protein in both disorders. Pathologic TDP-43 was hyper-phosphorylated, ubiquitinated, and cleaved to generate C-terminal fragments and was recovered only from affected central nervous system regions, including hippocampus, neocortex, and spinal cord. TDP-43 represents the common pathologic substrate linking these neurodegenerative disorders.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases

            A hallmark event in neurodegenerative diseases (NDs) is the misfolding, aggregation, and accumulation of proteins, leading to cellular dysfunction, loss of synaptic connections, and brain damage. Despite the involvement of distinct proteins in different NDs, the process of protein misfolding and aggregation is remarkably similar. A recent breakthrough in the field was the discovery that misfolded protein aggregates can self-propagate through seeding and spread the pathological abnormalities between cells and tissues in a manner akin to the behavior of infectious prions in prion diseases. This discovery has vast implications for understanding the mechanisms involved in the initiation and progression of NDs, as well as for the design of novel strategies for treatment and diagnosis. In this Review, we provide a critical discussion of the role of protein misfolding and aggregation in NDs. Commonalities and differences between distinct protein aggregates will be highlighted, in addition to evidence supporting the hypothesis that misfolded aggregates can be transmissible by the prion principle. We will also describe the molecular basis and implications for prion-like conformational strains, cross-interaction between different misfolded proteins in the brain, and how these concepts can be applied to the development of novel strategies for therapy and diagnosis.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Molecular mechanism of Thioflavin-T binding to amyloid fibrils.

              Intense efforts to detect, diagnose, and analyze the kinetic and structural properties of amyloid fibrils have generated a powerful toolkit of amyloid-specific molecular probes. Since its first description in 1959, the fluorescent dye Thioflavin-T (ThT) has become among the most widely used "gold standards" for selectively staining and identifying amyloid fibrils both in vivo and in vitro. The large enhancement of its fluorescence emission upon binding to fibrils makes ThT a particularly powerful and convenient tool. Despite its widespread use in clinical and basic science applications, the molecular mechanism for the ability of ThT to recognize diverse types of amyloid fibrils and for the dye's characteristic fluorescence has only begun to be elucidated. Here, we review recent progress in the understanding of ThT-fibril interactions at an atomic resolution. These studies have yielded important insights into amyloid structures and the processes of fibril formation, and they also offer guidance for designing the next generation of amyloid assembly diagnostics, inhibitors, and therapeutics. Copyright (c) 2010 Elsevier B.V. All rights reserved.
                Bookmark

                Author and article information

                Contributors
                cristiana.valle@cnr.it
                roberta.misasi@uniroma1.it
                Journal
                Mol Neurobiol
                Mol Neurobiol
                Molecular Neurobiology
                Springer US (New York )
                0893-7648
                1559-1182
                14 July 2023
                14 July 2023
                2023
                : 60
                : 11
                : 6346-6361
                Affiliations
                [1 ]GRID grid.7841.a, Department of Experimental Medicine, , University La Sapienza, ; 00185 Rome, Italy
                [2 ]GRID grid.417778.a, ISNI 0000 0001 0692 3437, IRCCS Fondazione Santa Lucia, ; 00179 Rome, Italy
                [3 ]Department of Systems Medicine, Tor Vergata” University of Rome, ( https://ror.org/02p77k626) 00133 Rome, Italy
                [4 ]Biomedicine and Advanced Technologies Rieti Center, Sabina Universitas, 02100 Rieti, Italy
                [5 ]GRID grid.5326.2, ISNI 0000 0001 1940 4177, Institute of Translational Pharmacology (IFT), , Consiglio Nazionale Delle Ricerche (CNR), ; 00185 Rome, Italy
                Author information
                http://orcid.org/0000-0002-1181-6190
                Article
                3455
                10.1007/s12035-023-03455-z
                10533643
                37450246
                de93b100-6a30-43b9-8ec0-968651cd43a4
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 1 February 2023
                : 17 June 2023
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100004710, Fondazione Umberto Veronesi;
                Award ID: Post-doctoral Fellowship 2021 - anno 2021
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/100007387, Fondazione Cassa di Risparmio di Pistoia e Pescia;
                Award ID: CUP B89J22001910007
                Award Recipient :
                Funded by: FundRef http://dx.doi.org/10.13039/501100021856, Ministero dell'Università e della Ricerca;
                Award ID: PRIN 20109MXHNR
                Award Recipient :
                Funded by: Università degli Studi di Roma La Sapienza
                Categories
                Original Article
                Custom metadata
                © Springer Science+Business Media, LLC, part of Springer Nature 2023

                Neurosciences
                tdp43,chronic stress,amyotrophic lateral sclerosis,prion,thioflavin
                Neurosciences
                tdp43, chronic stress, amyotrophic lateral sclerosis, prion, thioflavin

                Comments

                Comment on this article